This lecture by Pia Kamstrup was part of the EBAC-accredited symposium "Lp(a): from causality to therapy" held during the ESC congress 2022.
Pia Kamstrup, MD, PhD is Head of the Department of Clinical Biochemistry at the Copenhagen University Hospital – Herlev & Gentofte, Denmark.
This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of PACE-cme.
Funding for this educational program was provided by unrestricted educational grants from NewAmsterdam Pharma, Novartis, Sanofi and Roche Diagnostics.
Pia Kamstrup gives an overview of studies on Lp(a)-associated risk. She shows that elevated Lp(a) levels are associated with CVD and aortic valve stenosis, and that Lp(a)-associated risk is independent of other risk factors.